- Home
- PHLT vs CYBN Comparison
PHLT vs CYBN Comparison
Compare PHLT & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHLT
- CYBN
- Stock Information
- Founded
- PHLT 1976
- CYBN 2019
- Country
- PHLT United States
- CYBN Canada
- Employees
- PHLT N/A
- CYBN N/A
- Industry
- PHLT Other Consumer Services
- CYBN Pharmaceuticals and Biotechnology
- Sector
- PHLT Consumer Discretionary
- CYBN Health Care
- Exchange
- PHLT Nasdaq
- CYBN Nasdaq
- Market Cap
- PHLT 215.3M
- CYBN 177.9M
- IPO Year
- PHLT N/A
- CYBN N/A
- Fundamental
- Price
- PHLT $2.43
- CYBN $9.62
- Analyst Decision
- PHLT
- CYBN Strong Buy
- Analyst Count
- PHLT 0
- CYBN 3
- Target Price
- PHLT N/A
- CYBN $138.00
- AVG Volume (30 Days)
- PHLT 168.5K
- CYBN 213.0K
- Earning Date
- PHLT 03-11-2025
- CYBN 02-12-2025
- Dividend Yield
- PHLT N/A
- CYBN N/A
- EPS Growth
- PHLT N/A
- CYBN N/A
- EPS
- PHLT N/A
- CYBN N/A
- Revenue
- PHLT $120,782,000.00
- CYBN N/A
- Revenue This Year
- PHLT $9.72
- CYBN N/A
- Revenue Next Year
- PHLT $9.90
- CYBN N/A
- P/E Ratio
- PHLT N/A
- CYBN N/A
- Revenue Growth
- PHLT 9.39
- CYBN N/A
- 52 Week Low
- PHLT $2.29
- CYBN $6.50
- 52 Week High
- PHLT $4.35
- CYBN $19.84
- Technical
- Relative Strength Index (RSI)
- PHLT N/A
- CYBN 50.92
- Support Level
- PHLT N/A
- CYBN $8.83
- Resistance Level
- PHLT N/A
- CYBN $9.41
- Average True Range (ATR)
- PHLT 0.00
- CYBN 0.59
- MACD
- PHLT 0.00
- CYBN 0.02
- Stochastic Oscillator
- PHLT 0.00
- CYBN 52.65
About PHLT Performant Healthcare Inc. Common Stock
Performant Healthcare Inc delivers payment integrity solutions for its healthcare payer clients.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.